South and Central America Cancer Targeted Therapy Market Valued at USD 4.73 Billion in 2024 Supported by Expanding Cancer Care Infrastructure by 2031
Increasing cancer screening initiatives and improvements in early diagnosis are creating favorable conditions for the expansion of precision oncology treatments. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of 11.6% from 2025 to 2031. Cancer continues...
0 Commentaires 0 Parts 114 Vue 0 Aperçu